NEW YORK - Tiziana Life Sciences Ltd. (NASDAQ:TLSA), a biotech firm focused on immunomodulation therapies with a market ...

President and Acting President of UT Health San Antonio, Taylor Eighmy, has appointed Francisco G. Cigarroa, M.D., as the Senior Executive Vice President for Health Affairs & Health System at UT ...

The phage therapy market is experiencing significant growth due to the increasing prevalence of antibiotic-resistant infections and the growing interest in alternative treatments. Advances in ...

After a Stage 4 cancer diagnosis and a prognosis of 16 months to live, Katie Doble didn’t know whether she should plan her ...

Both Harvard University and Johns Hopkins University sites were recently added as participating sites in FLAMINGO-01 in the US and both principal investigators, Dr. Laura Spring and Dr. Cesar ...

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") is excited to announce that the prestigious medical journal Nature Medicine ...

One of the earliest proponents of evidence-based medicine, Professor David Sackett, wrote, “Good doctors use both individual ...

In an interview, Danielle Mitchell of BWICR discussed the importance of increasing diversity in clinical research and making ...

Stuart Therapeutics completed a Phase 3 trial for ST-100, a treatment for dry eye disease, involving a randomized, ...

GATC West Virginia played a role in a groundbreaking AI-powered analysis of a new liver cancer drug in development — an analysis that saved inestimable hours and dollars for the client. GATC West ...

A research team from the University of Minnesota Medical School recently received a three-year, $1.2 million grant from the National Institutes of Health to study the use of transcranial magnetic ...